News

AI-guided solutions to improve health outcomes for mothers and their babies
News

Monday, 05 February 2024 00:52

In our completed 500-patient Pilot study, Oli has shown significant promise in being able to provide early-warning for post-partum hemorrhage - the...

News

Friday, 18 November 2022 06:30

Baymatob has successfully completed a competitive selection process to join this year’s cohort of the ANDHealth+ commercialisation acceleration...

News

Monday, 21 March 2022 09:00

Sydney medical device company Baymatob has completed a placement of $4.215 million, with proceeds used to continue in-human clinical trials for its...

News

Friday, 04 March 2022 11:34

Baymatob™, a pioneer in women’s health and AI-guided monitoring for pregnancy and labour, is preparing for an exciting growth stage. In anticipation...

News

Friday, 08 October 2021 09:52

Baymatob™, a pioneer in women’s health and AI-guided monitoring for maternity and child birth, is excited to announce the appointment of Dr Sarah...

News

Tuesday, 24 August 2021 15:20

Today Baymatob™ welcomes the formal appointment of David O'Reilly to the Board of Directors. Possessing a wealth of experience across both the...

News

Monday, 16 August 2021 15:57

Baymatob TM , a MedTech company founded by a Sydney mother after her own traumatic birth experience, has developed a world-first labour monitoring...

News

Friday, 13 August 2021 13:09

Today Baymatob welcomes the formal appointment of Tony Barclay and Alwyn Reynolds to our Board of Directors. Baymatob has been lucky enough to...

News

Sunday, 20 December 2020 16:01

Some of the Baymatob™ team meeting prior to the launch at the Baymatob™ premises (source: Baymatob™) Today the Ingham Institute launched their...

News

Thursday, 12 November 2020 13:13

It is with great excitement that Baymatob™ released the Oli™ MK2 device today. This is the waterproof version of the Oli™ technology, designed...

News

Thursday, 02 April 2020 13:23

Baymatob TM has celebrated the arrival of their newest member, Baby Alex. Baby Alex is the third child of the company's CEO, Dr Sarah McDonald, and...

News

Wednesday, 21 August 2019 00:00

Baymatob TM has been awarded $2.96M by the NSW Medical Devices Fund to conduct pre-trial development on Oli TM . A total of four companies received...

News

Thursday, 27 June 2019 13:49

Baymatob TM CEO, Sarah McDonald, presented at The Big Idea event held as part of the 2019 Sydney Local Health District (SLHD) Innovation and...

News

Thursday, 06 June 2019 13:51

Baymatob TM CEO, Sarah McDonald, presented the work done to date and vision for Oli TM at BIO 2019 in Philadelphia USA. The presentation covered the...

News

Wednesday, 30 May 2018 14:14

Baymatob TM has won the peoples choice award in the 2018 Building Better Futures for Health Challenge. This is an annual challenge hosted by IDE...

News

Thursday, 26 October 2017 13:58

Baymatob TM CEO, Sarah McDonald, presented an embedded culture enquiry showcase presentation as part of the 2017 NSW Health Innovation Symposium...

News

Tuesday, 29 August 2017 14:05

Baymatob TM has been awarded $1.47M by the NSW Medical Devices Fund to further develop Oli TM . A total of four companies received funding for the...

News

Friday, 23 June 2017 14:06

Baymatob TM CEO, Sarah McDonald, presented a keynote presentation as part of the 2017 Sydney Local Health District (SLHD) Innovation and Research...

News

Wednesday, 31 May 2017 14:11

Baymatob TM was awarded three major prizes at the 2017 Medical Device Commercialisation Training Program (MDCTP) showcase evening. CEO Sarah...